CD133+/CD44+ cells phenotype has been reported to exert extensive proliferation, self-renewal, differentiation, and invasion in prostate and colorectal tumors [78,82], characteristics that corroborate the CSC phenotype. Here, PROM1 is linked to colorectal neoplasm.